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Background
Advanced skin carcinoma, according to TNM classifica-
tion, is as a lesion in stage III or IV (T3-T4, N0-N1,
M0-M1) greater than 5 cm in greatest diameter (T3). It
can infiltrate extradermal tissues (T4) or it can have
local lymph node metastasis (N1) or distant metastasis
(M1).
In a large percentage of these patients, local relapses
with deep infiltration, regional lymph node metastasis or
distant metastases may be encountered.
Current literature reports only few papers about
advanced stage casistics.
Therefore we reviewed our experience with elderly
patients presenting skin carcinomas in advanced stage,
to evaluate the incidence of this disorder among the
whole number of skin carcinomas, the operability of
those patients, the immediate clinical response to the
surgical treatment and their follow-up.
Materials and methods
From January 1st 2005 to June 30th 2009 we observed
and treated 412 patients with skin carcinomas
Only patients with confirmed histopathological diag-
nosis of skin carcinoma were included in the study. The
advanced stage of disease was established by physical
examination and instrumental imaging exams.
Results
The more frequent diagnoses were basal cell carcino-
mas, squamous cell carcinoma and porocarcinoma.
Among this group, we found 37 advanced stage carci-
nomas (T3-T4), that is 8.98 % of patients with skin
carcinoma.
All patients were over 75 years old with median age of
81 years (range 75-88). Most patients presented systemic
disorders. Thirty six out of 37 patients were surgically
operated. Only one was not operated because of his
severe heart failure.
In all patients within 1 month from the surgical
operation, all surgical flaps and grafts were well nour-
ished. One year later only 24 patients came to the
check-up and all of them were alive and without any
tumor relapse.
Conclusions
Our percentage of advanced stage skin carcinomas in
elderly people (8,9 %) is particularly notable in compari-
son with other casistics reported in the literature that
commonly present a percentage of about 3% [1-4].
We must take into account that our Institute is sited
in the center of Calabria, a region of Southern Italy
quite homogeneous for population and lifestyle. Many
inhabitants are old and with a history of working as
fishermen or farmers and consequently exposed for long
periods to the sun rays.
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